The Treatment of Advanced Gastric Cancer: In Search of the Right Combination

2000 ◽  
Vol 18 (14) ◽  
pp. 2645-2647 ◽  
Author(s):  
Matthew H. Kulke
Keyword(s):  
Gastric Cancer ◽  
Advanced Gastric Cancer ◽  
The Right

scholarly journals Oxaliplatin-Associated Amaurosis Fugax

2021 ◽  
pp. 832-837
Author(s):  
Kimitoshi Kubo ◽  
Noriko Kimura ◽  
Ryosuke Watanabe ◽  
Masayuki Higashino ◽  
Momoko Tsuda ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Visual Field ◽  
Advanced Gastric Cancer ◽  
Clinical Course ◽  
Amaurosis Fugax ◽  
First Report ◽  
Loss Of Vision ◽  
Daily Frequency ◽  
The Right ◽  
Visual Field Impairment

Oxaliplatin-associated amaurosis fugax has not been reported, and its clinical course and treatment remain largely unclear. A 70-year-old man with advanced gastric cancer was treated with the SOX regimen. After cycle 1 of oxaliplatin infusion, the patient realized that his right eye had visual field impairment, which he described as darkening of the right half of his visual field and loss of vision lasting about 1 min and occurring about 7 times a day. The daily frequency of this occurrence gradually decreased, and his visual field impairment improved in 1 week. However, as the same symptoms recurred from cycle 2 to cycle 5 of treatment, oxaliplatin was discontinued from cycle 6 and switched to S-1 monotherapy. Subsequently, the patient’s amaurosis fugax improved. To our knowledge, this is the first report describing clinical course and treatment of oxaliplatin-associated amaurosis fugax.

CPT-11/Cisplatin neoadjuvant therapy downstages locally advanced gastric cancer

2001 ◽  
Vol 120 (5) ◽  
pp. A129-A129
Author(s):  
E NEWMAN ◽  
S MARCUS ◽  
M POTMESIL ◽  
H HOCHSTER ◽  
H YEE ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Neoadjuvant Therapy ◽  
Advanced Gastric Cancer ◽  
Locally Advanced ◽  
Locally Advanced Gastric Cancer
Sign in / Sign up

Export Citation Format

Share Document